Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials. BMC Cancer / Omarini, C; Piacentini, F; Sperduti, I; Barbolini, M; Isca, C; Toss, A; Cortesi, L; Barbieri, E; Dominici, M; Moscetti, L. - In: BMC CANCER. - ISSN 1471-2407. - (2020), pp. 418-425.
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials. BMC Cancer
Omarini CConceptualization
;Isca CWriting – Review & Editing
;Toss AWriting – Review & Editing
;Cortesi LWriting – Review & Editing
;Dominici MSupervision
;Moscetti LSupervision
2020
| File | Dimensione | Formato | |
|---|---|---|---|
|
BMC2020.pdf
Open access
Tipologia:
VOR - Versione pubblicata dall'editore
Dimensione
1.82 MB
Formato
Adobe PDF
|
1.82 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
